London, United Kingdom | full time | Job ID: 9739
BioNTech is establishing a cutting-edge genomics hub in Cambridge, UK, to support our clinical studies and advance genomics approaches for our individualized mRNA cancer vaccine platforms. As part of this initiative, we are building substantial next-generation sequencing (NGS) capacities in Cambridge to support our clinical trials and individualized mRNA cancer vaccine manufacture via diagnostic applications and neoantigen discovery.
We are seeking an experienced and visionary Site Head to lead and oversee the operations of a GxP-compliant genomics laboratory specializing in Illumina sequencing technology for whole exome sequencing (WES) and RNA sequencing (RNA-Seq).
In this role, you will own the end-to-end management of the genomics workflow, ensuring seamless execution and impactful results. With your expertise in technology transfer, instrument qualification, analytical method validation, and laboratory information management systems (LIMS), you will set the standard for operational excellence and regulatory compliance.
MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.